EORTC trial non-Hodgkin lymphomas
- 1 March 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (3) , 283-293
- https://doi.org/10.1016/0277-5379(87)90072-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Reproducibility and prognostic value of different non-Hodgkin's lymphoma classifications: Study based on the clinicopathologic relations found in the EORTC trial (20751)European Journal of Cancer and Clinical Oncology, 1985
- The Natural History of Initially Untreated Low-Grade Non-Hodgkin's LymphomasNew England Journal of Medicine, 1984
- Diffuse Aggressive Lymphomas: Increased Survival After Alternating Flexible Sequences of ProMACE and MOPP ChemotherapyAnnals of Internal Medicine, 1983
- Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic typesCancer, 1980
- Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-hodgkin's lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 1980
- CVP—Remission—maintenance in stage I or II non-Hodgkin's lymphomasPreliminary results of a randomized studyCancer, 1979
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958